Page 17 - Generation Bio News Today : Breaking News, Live Up

Cell therapy | BioPharma Dive

Published: June 1, 2022

BioPharma

Forge Biologics Forms Independent Scientific and Manufacturing Advisory Board with Panel of Gene Therapy Leaders

Published: May 17, 2022

Forge Biologics Forms Independent Scientific and Manufacturing Advisory Board with Panel of Gene Therapy Leaders - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com

Generation Bio (NASDAQ:GBIO) Downgraded to Hold at Zacks Investment Research

Published: April 1, 2022

Zacks Investment Research lowered shares of Generation Bio (NASDAQ:GBIO – Get Rating) from a buy rating to a hold rating in a report published on Monday, Zacks.com reports. According to Zacks, “Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. […]

Source: etfdailynews.com

As biotech retreats, gene therapy companies retrench and redraw plans

Published: March 24, 2022

BioPharma

Source: biopharmadive.com

Vir Biotechnology (NASDAQ:VIR) & Allogene Therapeutics (NASDAQ:ALLO) Head-To-Head Contrast

Published: March 5, 2022

Vir Biotechnology (NASDAQ:VIR – Get Rating) and Allogene Therapeutics (NASDAQ:ALLO – Get Rating) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability. Analyst Ratings This is a summary of current ratings and […]